Kun Mu

3.2k total citations
59 papers, 1.6k citations indexed

About

Kun Mu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Kun Mu has authored 59 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 18 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Kun Mu's work include Cancer-related Molecular Pathways (6 papers), Spine and Intervertebral Disc Pathology (6 papers) and Pregnancy-related medical research (5 papers). Kun Mu is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Spine and Intervertebral Disc Pathology (6 papers) and Pregnancy-related medical research (5 papers). Kun Mu collaborates with scholars based in China, United States and Sweden. Kun Mu's co-authors include Lihui Han, Wei Zhao, Pengbo Guo, Tao Li, Qing Wei, Wanwan Huai, Ying Zhang, Zhaowen Yang, Xiaoqing Jia and Xiaomin Ma and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Kun Mu

57 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kun Mu China 23 949 419 310 293 222 59 1.6k
Kirsi‐Maria Haapasaari Finland 24 674 0.7× 437 1.0× 337 1.1× 176 0.6× 180 0.8× 76 1.5k
Qingchang Li China 27 1.3k 1.4× 575 1.4× 435 1.4× 239 0.8× 272 1.2× 110 2.2k
Nicolas Chapuis France 26 1.8k 1.9× 466 1.1× 399 1.3× 303 1.0× 290 1.3× 74 2.7k
Eliza Wiercinska Germany 22 1.1k 1.2× 788 1.9× 316 1.0× 263 0.9× 194 0.9× 41 2.1k
Hao Wen China 26 981 1.0× 453 1.1× 517 1.7× 189 0.6× 274 1.2× 103 2.1k
Chenghai Zhao China 25 1.1k 1.1× 541 1.3× 437 1.4× 405 1.4× 197 0.9× 61 1.8k
Shaolei Lu United States 22 582 0.6× 474 1.1× 274 0.9× 162 0.6× 169 0.8× 81 1.4k
Wenfeng Cao China 22 947 1.0× 396 0.9× 456 1.5× 138 0.5× 225 1.0× 59 1.6k
Shumei Yan China 22 619 0.7× 458 1.1× 365 1.2× 193 0.7× 312 1.4× 58 1.3k

Countries citing papers authored by Kun Mu

Since Specialization
Citations

This map shows the geographic impact of Kun Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Mu more than expected).

Fields of papers citing papers by Kun Mu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Mu. The network helps show where Kun Mu may publish in the future.

Co-authorship network of co-authors of Kun Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Kun Mu. A scholar is included among the top collaborators of Kun Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun Mu. Kun Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mu, Kun, Jingshu Geng, Yu Dong, et al.. (2025). ATF1 and miR-27b-3p drive intervertebral disc degeneration through the PPARG/NF-κB signaling axis. Communications Biology. 8(1). 751–751. 1 indexed citations
2.
Li, Qiuyu, et al.. (2025). A148 NOD2 LIGAND AND PEPTIDOGLYCAN HYDROLASE GENE ABUNDANCES ARE ALTERED IN PRE-CROHN’S DISEASE. Journal of the Canadian Association of Gastroenterology. 8(Supplement_1). i61–i61. 1 indexed citations
3.
4.
Chen-Liaw, Alice, Andrew A. Luchak, Irwindeep Sandhu, et al.. (2024). A1 PRE-CLINICAL CROHN’S DISEASE MICROBIOME PROMOTES INFLAMMATION IN GNOTOBIOTIC RECIPIENT MICE. Journal of the Canadian Association of Gastroenterology. 7(Supplement_1). 1–1. 1 indexed citations
5.
6.
Guo, Wei-Feng, et al.. (2023). Identification of mitochondria-related key gene and association with immune cells infiltration in intervertebral disc degeneration. Frontiers in Genetics. 14. 1135767–1135767. 9 indexed citations
7.
Wang, Depeng, Wei Xu, Wei Ma, et al.. (2023). CENPF knockdown inhibits adriamycin chemoresistance in triple-negative breast cancer via the Rb-E2F1 axis. Scientific Reports. 13(1). 1803–1803. 10 indexed citations
8.
Zhang, Cuiyu, Yu‐Ping Zhou, Nannan Ning, et al.. (2022). Inhibition of GABAA receptors in intestinal stem cells prevents chemoradiotherapy-induced intestinal toxicity. The Journal of Experimental Medicine. 219(12). 14 indexed citations
9.
Zhuo, Shu, Ting Zhuang, Yong Suk Cho, et al.. (2022). YAP inhibits ERα and ER+ breast cancer growth by disrupting a TEAD-ERα signaling axis. Nature Communications. 13(1). 3075–3075. 51 indexed citations
10.
Wang, Depeng, et al.. (2022). Immunohistochemical staining of LEF-1 is a useful marker for distinguishing WNT-activated medulloblastomas. Diagnostic Pathology. 17(1). 69–69. 5 indexed citations
11.
Xing, Ai‐Yan, et al.. (2022). Rare Recurrent EWSR1-PLAGL1 Rearranged Intracranial Tumor With Biphasic Epithelioid Differentiation: One Case Report With Literature Review. Frontiers in Oncology. 12. 938385–938385. 2 indexed citations
12.
Xue, Min, Kai Zhang, Kun Mu, et al.. (2019). Regulation of estrogen signaling and breast cancer proliferation by an ubiquitin ligase TRIM56. Oncogenesis. 8(5). 30–30. 74 indexed citations
13.
Zhang, Bin, Wei Guo, Chao Sun, et al.. (2018). Dysregulated MiR-3150a-3p Promotes Lumbar Intervertebral Disc Degeneration by Targeting Aggrecan. Cellular Physiology and Biochemistry. 45(6). 2506–2515. 25 indexed citations
14.
Yang, Huijie, Sifan Yu, Weilong Wang, et al.. (2017). SHARPIN Facilitates p53 Degradation in Breast Cancer Cells. Neoplasia. 19(2). 84–92. 37 indexed citations
15.
Mu, Kun, Li Li, Pedram Kharaziha, et al.. (2015). A standardized method for quantifying proliferation by Ki-67 and cyclin A immunohistochemistry in breast cancer. Annals of Diagnostic Pathology. 19(4). 243–248. 18 indexed citations
16.
Wei, Qing, Pengbo Guo, Kun Mu, et al.. (2015). Estrogen suppresses hepatocellular carcinoma cells through ERβ-mediated upregulation of the NLRP3 inflammasome. Laboratory Investigation. 95(7). 804–816. 116 indexed citations
17.
Yu, Chengcheng, Zhaowen Yang, Qing Wei, et al.. (2013). Deregulated NLRP3 and NLRP1 Inflammasomes and Their Correlations with Disease Activity in Systemic Lupus Erythematosus. The Journal of Rheumatology. 41(3). 444–452. 71 indexed citations
18.
Zhang, Qiang, Liyuan Liu, Fei Wang, Kun Mu, & Zhigang Yu. (2012). The changes in female physical and childbearing characteristics in china and potential association with risk of breast cancer. BMC Public Health. 12(1). 368–368. 33 indexed citations
19.
Mu, Kun, Li Li, Tingguo Zhang, et al.. (2011). Detection of CHK1 and CCND1 gene copy number changes in breast cancer with dual‐colour fluorescence in‐situ hybridization. Histopathology. 58(4). 601–607. 12 indexed citations
20.
Wang, Jing, et al.. (2009). Low‐dose metronomic chemotherapy with cisplatin: can it suppress angiogenesis in H22 hepatocarcinoma cells?. International Journal of Experimental Pathology. 91(1). 10–16. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kirsi‐Maria Haapasaari Breakdown of academic impact, for papers by Qingchang Li Breakdown of academic impact, for papers by Nicolas Chapuis Breakdown of academic impact, for papers by Eliza Wiercinska Breakdown of academic impact, for papers by Hao Wen Breakdown of academic impact, for papers by Chenghai Zhao Breakdown of academic impact, for papers by Shaolei Lu Breakdown of academic impact, for papers by Wenfeng Cao Breakdown of academic impact, for papers by Shumei Yan
Rankless by CCL
2026